Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

167.32 USD -0.52 (-0.31%)
Streaming Delayed Price Updated: 2:49 PM EST, Jan 18, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,739,530
Open 167.10
Bid (Size) 167.32 (2)
Ask (Size) 167.34 (15)
Prev. Close 167.84
Today's Range 166.01 - 167.72
52wk Range 151.47 - 179.92
Shares Outstanding 2,628,679,824
Dividend Yield 2.41%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
How Johnson & Johnson's Innovative Supply Chain Technology is Helping Transform How We Work - and Live
Tags j&j supply chain Innovation & Technology
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Novavax Still Has Not Received an FDA EUA as the Market Waits
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Novavax still has not received EUA from the FDA as the market waits for approval. NVAX stock looks like a good buy here, especially if... 
Tags JNJ Stocks to Buy AZN
From InvestorPlace

Performance

YTD
-2.46%
-2.46%
1 Month
-0.26%
-0.26%
3 Month
+4.50%
+4.50%
6 Month
+0.26%
+0.26%
1 Year
+2.79%
+2.79%

More News

Read More
10 Health Care Stocks Whale Activity In Today's Session
Tags MRNA SAVA Benzinga
From Benzinga
Here's Some Good News for Novavax That Investors Are Overlooking
Tags Recent Press Releases NVAX JNJ
From Motley Fool
What To Expect When Johnson & Johnson Unveils Q4 Performance This Month
Tags General Analyst Ratings JNJ
From Benzinga
3 Top Dividend Stocks on Robinhood's Most Popular List
Tags XOM Recent Press Releases PFE
From Motley Fool
Why Moderna, Novavax And Other Vaccine Stocks Are Extending Losses Today
Tags Trading Ideas Top Stories Vaccines
From Benzinga
Top Best Blue-Chip Stocks To Buy In 2022
Tags Market News Stocks / Equities
From TalkMarkets
Johnson and Johnson' COVID-19 Booster Is 85% Effective Against Omicron Hospitalization, South African Study Shows
Tags Briefs General JNJ
From Benzinga
Johnson & Johnson: Dividend King To Hold In A Market Crash
Tags Market News Stocks / Equities
From TalkMarkets
This Company Says Its Developing a COVID-19 Vaccine That Can be Taken Orally
Tags Market News BNTX ORMP
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.